Pharmacology Case Studies: Hypothyroidism, Diabetes & GERD
This paper presents four clinical pharmacology case studies addressing common chronic conditions. The first case examines hypothyroidism management with levothyroxine in a patient with concurrent iron deficiency anemia. The second case explores antidiabetic therapy selection for a patient with Type II diabetes mellitus and chronic kidney disease, where renal impairment rules out metformin. The third case covers glucose control optimization in a commercial truck driver with poorly controlled diabetes and a sulfa allergy. The fourth case addresses refractory GERD management in an elderly woman, including escalation to a prescription-strength proton pump inhibitor and lifestyle modifications. Each case includes a medication order, monitoring plan, and patient education considerations.
- Hypothyroidism Management with Levothyroxine: Levothyroxine prescription, monitoring, and patient education
- Type II Diabetes and Chronic Kidney Disease: Dapagliflozin as metformin alternative in renal impairment
- Diabetes Management in a Commercial Driver: Empagliflozin addition for poorly controlled diabetes
- GERD Management in an Elderly Patient: Esomeprazole escalation and lifestyle modification for GERD
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Each case study follows a consistent, clinically organized structure — problem description, medication order, monitoring plan, and patient education — making the reasoning easy to follow and evaluate.
- Drug selection is explicitly justified by patient-specific contraindications (e.g., renal impairment ruling out metformin, sulfa allergy influencing SGLT2 inhibitor choice), demonstrating applied clinical reasoning rather than rote prescription.
- Patient education sections address not only correct drug use but also side-effect awareness and lifestyle factors, reflecting a holistic approach to pharmacological management.
Key academic technique demonstrated
The paper consistently links pharmacological decisions to clinical evidence through in-text citations, grounding each treatment choice in peer-reviewed literature. This evidence-based reasoning technique — stating the clinical problem, selecting an agent, and supporting that selection with a citation — is a core skill in graduate-level health sciences writing.
Structure breakdown
The paper is divided into four parallel case studies, each self-contained with its own references. Within each case, the structure moves from diagnosis and problem framing, to the specific medication order, to monitoring parameters, and finally to patient education. This parallel structure allows readers to compare clinical decision-making across different conditions and patient populations.
Hypothyroidism Management with Levothyroxine
A 35-year-old female patient has been diagnosed with hypothyroidism, as evidenced by an elevated Thyroid-Stimulating Hormone (TSH) level of 20. She also suffers from iron deficiency anemia, as indicated by low MCV, MCHC, and ferritin values along with a high Total Iron Binding Capacity (TIBC). Her current regimen includes non-prescription kelp tablets, ibuprofen as needed, and a contraceptive pill.
Given her high TSH levels and symptoms, treatment with levothyroxine is initiated to regulate thyroid function (Wilson et al., 2021). An appropriate starting dose, assuming a body weight of approximately 70 kg, is as follows.
Levothyroxine 75 mcg orally, once daily in the morning on an empty stomach; the patient should not eat for 30 minutes post-administration.
Monitoring should involve checking TSH and free T4 levels 6–8 weeks after initiation to adjust the dosage accordingly. Continuous monitoring every 6–12 months after stabilization is necessary (Ross, 2022).
The patient should be informed about the importance of taking levothyroxine alone, without other concurrent medications or supplements — especially iron, which can interfere with its absorption (Wiesner et al., 2021). The necessity of consistent daily intake at the same time each day should be emphasized to ensure effective treatment of hypothyroidism.
Ross, D. S. (2022). Treating hypothyroidism is not always easy: when to treat subclinical hypothyroidism, TSH goals in the elderly, and alternatives to levothyroxine monotherapy. Journal of Internal Medicine, 291(2), 128–140.
Wiesner, A., Gajewska, D., & Pałko, P. (2021). Levothyroxine interactions with food and dietary supplements — a systematic review. Pharmaceuticals, 14(3), 206.
Wilson, S. A., Stem, L. A., & Bruehlman, R. D. (2021). Hypothyroidism: Diagnosis and treatment. American Family Physician, 103(10), 605–613.
Type II Diabetes and Chronic Kidney Disease
A 48-year-old male with Type II Diabetes Mellitus presents with poorly controlled blood glucose levels, as indicated by a fasting blood glucose of 225 mg/dL and an HbA1c of 7.5%. He also has chronic kidney disease (CKD) with an eGFR of 28 and elevated creatinine levels.
Given his diabetic condition coupled with CKD, careful selection of antidiabetic medication is crucial. Metformin is generally the first-line agent; however, his renal function prohibits its use (Song et al., 2021). A suitable alternative is as follows.
Dapagliflozin 10 mg orally, once daily before breakfast.
The patient's response to dapagliflozin should be closely monitored through regular kidney function tests and HbA1c levels every 3 months to assess efficacy and kidney health (Jabbour et al., 2020). Blood pressure and cardiovascular status should also be regularly evaluated.
It is important to educate the patient on recognizing signs of hypoglycemia and the importance of maintaining a balanced diet alongside medication. He should also be informed about the potential for increased urination and signs of urinary tract infections, as these are common side effects of SGLT2 inhibitors like dapagliflozin (Mayhoub et al., 2022).
Jabbour, S. A., Frías, J. P., Ahmed, A., Hardy, E., Choi, J., Sjöström, C. D., & Guja, C. (2020). Efficacy and safety over 2 years of exenatide plus dapagliflozin in the DURATION-8 study: a multicenter, double-blind, phase 3, randomized controlled trial. Diabetes Care, 43(10), 2528–2536.
Mayhoub, H., BouBou, A., & Kaddar, N. (2022). Assessment of genital and urinary tract infections in patients with Type 2 Diabetes Mellitus treated with dapagliflozin. Bulletin of Pharmaceutical Sciences. Assiut, 45(2), 953–965.
Song, A., Zhang, C., & Meng, X. (2021). Mechanism and application of metformin in kidney diseases: An update. Biomedicine & Pharmacotherapy, 138, 111454.
Always verify citation format against your institution’s current style guide requirements.